Deprescribing statins for adults 65 years of age and older: Evidence-based clinical practice guideline.
Evidence-based guidance helps doctors safely reduce statin use in older adults taking multiple medications where benefits may no longer outweigh risks.
This GRADE-based clinical practice guideline provides the first systematic evidence synthesis and actionable decision framework for statin deprescribing in older adults, addressing polypharmacy, frailty, and life expectancy factors that are underweighted in current lipid-lowering guidelines. Given that statins are the most commonly prescribed drug class in adults ≥65, this guidance has immediate population-scale implications for prescribing practice.
What the study was
- Study design
- Evidence-based clinical practice guideline (systematic review + GRADE)
- Population
- Adults aged ≥65 currently prescribed statins
- Category
- Public Health
- Maturity
- Potentially Practice-Changing
- Journal
- Canadian family physician Medecin de famille canadien
Why it surfaced
First evidence-based deprescribing guideline for statins in elderly; directly implementable by primary care/geriatric clinicians managing the most prescribed drug class in the over-65 population.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.